1. Home
  2. TECH vs VFS Comparison

TECH vs VFS Comparison

Compare TECH & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • VFS
  • Stock Information
  • Founded
  • TECH 1976
  • VFS 2017
  • Country
  • TECH United States
  • VFS Vietnam
  • Employees
  • TECH N/A
  • VFS N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • VFS Blank Checks
  • Sector
  • TECH Health Care
  • VFS Finance
  • Exchange
  • TECH Nasdaq
  • VFS Nasdaq
  • Market Cap
  • TECH 7.8B
  • VFS 8.2B
  • IPO Year
  • TECH 1989
  • VFS N/A
  • Fundamental
  • Price
  • TECH $53.94
  • VFS $3.53
  • Analyst Decision
  • TECH Buy
  • VFS Buy
  • Analyst Count
  • TECH 12
  • VFS 3
  • Target Price
  • TECH $70.00
  • VFS $5.75
  • AVG Volume (30 Days)
  • TECH 1.9M
  • VFS 513.5K
  • Earning Date
  • TECH 08-06-2025
  • VFS 06-09-2025
  • Dividend Yield
  • TECH 0.59%
  • VFS N/A
  • EPS Growth
  • TECH N/A
  • VFS N/A
  • EPS
  • TECH 0.83
  • VFS N/A
  • Revenue
  • TECH $1,208,770,000.00
  • VFS $2,103,991,902.00
  • Revenue This Year
  • TECH $7.07
  • VFS N/A
  • Revenue Next Year
  • TECH $5.72
  • VFS $40.04
  • P/E Ratio
  • TECH $65.29
  • VFS N/A
  • Revenue Growth
  • TECH 4.72
  • VFS 65.72
  • 52 Week Low
  • TECH $46.01
  • VFS $2.56
  • 52 Week High
  • TECH $83.62
  • VFS $5.38
  • Technical
  • Relative Strength Index (RSI)
  • TECH 59.94
  • VFS 49.81
  • Support Level
  • TECH $50.97
  • VFS $3.45
  • Resistance Level
  • TECH $55.53
  • VFS $3.75
  • Average True Range (ATR)
  • TECH 2.07
  • VFS 0.12
  • MACD
  • TECH 0.24
  • VFS -0.01
  • Stochastic Oscillator
  • TECH 77.60
  • VFS 43.93

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

Share on Social Networks: